Predictive Role of Selected Biomarkers in Differentiating Gram-positive from Gram-negative Sepsis in Surgical Patients: a Retrospective Study

Overview

Journal Anaesthesiol Intensive Ther

Specialties Anesthesiology
Critical Care

Date 2024 Jan 29

PMID 38282497

Authors

Nenad Neskovic

Domagoj Drenjancevic

Slavica Kvolik

Sonja Skiljic

Dino Budrovac

Ivana Harsanji Drenjancevic

Affiliations

Soon will be listed here.

Abstract

Introduction: Patients after major surgery are at high risk of developing sepsis, which is accompanied by elevated serum levels of C-reactive protein (CRP) and procalcitonin (PCT). This study aimed to examine the differences in serum biomarker levels concerning the causative agent of sepsis in surgical patients.

Material And Methods: A retrospective study was carried out in the surgical intensive care unit (ICU) and included 81 septic patients admitted from January 2019 to May 2022, who had positive blood cultures (BC). Serum levels of PCT, CRP, white blood cells (WBC) and platelet counts were recorded on the day of the positive BC and over the following 3 days.

Results: Patients with gram(-) sepsis had significantly higher PCT levels, and lower platelet count compared to patients with gram(+) sepsis. High PCT and low platelets levels in all measurements were a significant predictor of gram(-) isolate with the highest predictive value on the third day after BC sampling, with AUROC 0.821 (95% CI: 0.692-0.950), P = 0.001, and AUROC 0.676 (95% CI: 0.541-0.811), P = 0.02, respectively. In multivariate logistic regression, platelets the day after BC sampling and PCT on the third day made a significant contribution in distinguishing gam(+) from gram(-) BC. Age and high serum CRP levels were significant predictors of poor outcomes.

Conclusions: PCT and platelets may be useful biomarkers for predicting the causative agent of sepsis in surgical patients.

Citing Articles

The impact of COVID-19 pandemic on nosocomial infections in the cardiac care unit of a non-epidemic hospital in China.

Liao X, Wu W, Zhang L, Zhang Z, Zheng C, Qiu X Front Med (Lausanne). 2025; 12:1483967.

PMID: 39902236 PMC: 11788138. DOI: 10.3389/fmed.2025.1483967.

Usefulness of Procalcitonin Levels for Predicting the Microbiological Orientation in Patients with Sepsis.

Pascual Gomez N, Del Pilar Sanz Martin M, Chong M, Cruz N, Hernandez R, Molina I J Pers Med. 2024; 14(2).

PMID: 38392641 PMC: 10890570. DOI: 10.3390/jpm14020208.

References

Li S, Rong H, Guo Q, Chen Y, Zhang G, Yang J . Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci. 2016; 21:39. PMC: 5122113. DOI: 10.4103/1735-1995.183996. View

Gupta S, Sakhuja A, Kumar G, McGrath E, Nanchal R, Kashani K . Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes. Chest. 2016; 150(6):1251-1259. DOI: 10.1016/j.chest.2016.08.1460. View

Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J . Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood. 2006; 109(4):1574-83. DOI: 10.1182/blood-2006-06-032961. View

Varadaradjalou S, Feger F, Thieblemont N, Ben Hamouda N, Pleau J, Dy M . Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol. 2003; 33(4):899-906. DOI: 10.1002/eji.200323830. View

Santonocito C, De Loecker I, Donadello K, Moussa M, Markowicz S, Gullo A . C-reactive protein kinetics after major surgery. Anesth Analg. 2014; 119(3):624-629. DOI: 10.1213/ANE.0000000000000263. View

Wacker C, Prkno A, Brunkhorst F, Schlattmann P . Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013; 13(5):426-35. DOI: 10.1016/S1473-3099(12)70323-7. View

Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U . Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med. 1999; 134(1):49-55. DOI: 10.1016/s0022-2143(99)90053-7. View

McSorley S, Khor B, MacKay G, Horgan P, McMillan D . Examination of a CRP first approach for the detection of postoperative complications in patients undergoing surgery for colorectal cancer: A pragmatic study. Medicine (Baltimore). 2017; 96(7):e6133. PMC: 5319530. DOI: 10.1097/MD.0000000000006133. View

Venkata C, Kashyap R, Farmer J, Afessa B . Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome. J Intensive Care. 2015; 1(1):9. PMC: 4373028. DOI: 10.1186/2052-0492-1-9. View

10.

Demirdal T, Sen P, Nemli S . Diagnostic Value of Procalcitonin in Predicting Bacteremia in Intensive Care Unit. Indian J Crit Care Med. 2018; 22(2):78-84. PMC: 5842461. DOI: 10.4103/ijccm.IJCCM_437_17. View

11.

Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T . Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999; 11(4):443-51. DOI: 10.1016/s1074-7613(00)80119-3. View

12.

Dolmatova E, Wang K, Mandavilli R, Griendling K . The effects of sepsis on endothelium and clinical implications. Cardiovasc Res. 2020; 117(1):60-73. PMC: 7810126. DOI: 10.1093/cvr/cvaa070. View

13.

Gupta S, Jaswani P, Sharma R, Agrawal S, Prasad N, Sahu C . Procalcitonin as a diagnostic biomarker of sepsis: A tertiary care centre experience. J Infect Public Health. 2018; 12(3):323-329. DOI: 10.1016/j.jiph.2018.11.004. View

14.

Salomao R, Ferreira B, Salomao M, Santos S, Azevedo L, Brunialti M . Sepsis: evolving concepts and challenges. Braz J Med Biol Res. 2019; 52(4):e8595. PMC: 6472937. DOI: 10.1590/1414-431X20198595. View

15.

Maves R, Enwezor C . Uses of Procalcitonin as a Biomarker in Critical Care Medicine. Infect Dis Clin North Am. 2022; 36(4):897-909. DOI: 10.1016/j.idc.2022.07.004. View

16.

Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C . High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993; 341(8844):515-8. PMC: 7141580. DOI: 10.1016/0140-6736(93)90277-n. View

17.

Engoren M, Seelhammer T, Freundlich R, Maile M, Sigakis M, Schwann T . A Comparison of Sepsis-2 (Systemic Inflammatory Response Syndrome Based) to Sepsis-3 (Sequential Organ Failure Assessment Based) Definitions-A Multicenter Retrospective Study. Crit Care Med. 2020; 48(9):1258-1264. PMC: 7484263. DOI: 10.1097/CCM.0000000000004449. View

18.

Zhang D, Sun M, Samols D, Kushner I . STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem. 1996; 271(16):9503-9. DOI: 10.1074/jbc.271.16.9503. View

19.

Leli C, Ferranti M, Moretti A, Al Dhahab Z, Cenci E, Mencacci A . Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. 2015; 2015:701480. PMC: 4380090. DOI: 10.1155/2015/701480. View

20.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View